A Study of BL-B16D1 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors

NCT06469008 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Head and Neck Squamous Cell Carcinomas
Solid Tumor

Interventions

DRUG: BL-B16D1

Sponsor

Sichuan Baili Pharmaceutical Co., Ltd.

Collaborators

[object Object]